Natera, Inc. (NTRA)
404.79
+10.04
(+2.54%)
USD |
NASDAQ |
Oct 15, 16:00
404.80
+0.01
(+0.00%)
After-Hours: 04:38
Natera Cash from Operations (TTM) : 228.24M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 228.24M |
| March 31, 2026 | 211.02M |
| December 31, 2025 | 215.30M |
| September 30, 2025 | 194.30M |
| June 30, 2025 | 186.70M |
| March 31, 2025 | 153.12M |
| December 31, 2024 | 135.66M |
| September 30, 2024 | 24.65M |
| June 30, 2024 | -56.69M |
| March 31, 2024 | -139.06M |
| December 31, 2023 | -246.96M |
| September 30, 2023 | -269.96M |
| June 30, 2023 | -342.65M |
| March 31, 2023 | -375.11M |
| December 31, 2022 | -431.50M |
| September 30, 2022 | -449.11M |
| June 30, 2022 | -437.92M |
| March 31, 2022 | -397.64M |
| December 31, 2021 | -335.24M |
| September 30, 2021 | -309.80M |
| June 30, 2021 | -251.87M |
| March 31, 2021 | -222.29M |
| Date | Value |
|---|---|
| December 31, 2020 | -182.51M |
| September 30, 2020 | -124.26M |
| June 30, 2020 | -103.77M |
| March 31, 2020 | -66.72M |
| December 31, 2019 | -63.44M |
| September 30, 2019 | -61.20M |
| June 30, 2019 | -71.84M |
| March 31, 2019 | -103.45M |
| December 31, 2018 | -70.58M |
| September 30, 2018 | -85.90M |
| June 30, 2018 | -93.93M |
| March 31, 2018 | -72.16M |
| December 31, 2017 | -97.82M |
| September 30, 2017 | -99.29M |
| June 30, 2017 | -92.29M |
| March 31, 2017 | -99.22M |
| December 31, 2016 | -74.05M |
| September 30, 2016 | -49.18M |
| June 30, 2016 | -42.12M |
| March 31, 2016 | -34.55M |
| December 31, 2015 | -37.56M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Guardant Health, Inc. | -173.00M |
| Myriad Genetics, Inc. | 7.70M |
| CareDx, Inc. | 93.66M |
| Caris Life Sciences, Inc. | 160.85M |
| BioRestorative Therapies, Inc. | -11.82M |